Top news

View all

6 March 2023

Spain to co-host 2023 Vaccine Alliance High-Level Summit on Immunisation

The high-level summit, co-hosted by Gavi and Spain, will be an opportunity to look back on the immunisation strategy outlined by the Vaccine Alliance at 2020’s Global Vaccine Summit in London.

13 February 2023

Dr Muhammad Ali Pate to become next CEO of Gavi, the Vaccine Alliance

The Gavi Board has approved the appointment of Dr Muhammad Ali Pate as the Chief Executive Officer of the Vaccine Alliance following an extensive recruitment process.

7 February 2023

Gavi welcomes appointment of global health leader and malaria expert Dr Rose Leke as Chair of Independent Review Committee

The Gavi Independent Review Committee (IRC) is responsible for reviewing all applications for new funding support submitted by Gavi-eligible countries.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published every two weeks.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

31 March 2023

What is antimicrobial resistance and how can we tackle it?

Antimicrobial resistance is a growing threat which is exacerbated by overuse of antibiotics - as well as poor waste management and climate change. 

31 March 2023

Trans and gender-diverse people face higher risk of some cancers, and a higher risk of those cancers being missed

HPV-linked cancers – which are vaccine preventable in most cases – are a particular threat to trans people, a review study recently found. 

31 March 2023

Trans people are overlooked by immunisation programmes. That needs to change

Discrimination and marginalisation of any kind constitute a multi-layered public health threat. Trans people, finds Rachel Sadoff, are at greater risk not just of violence, but also from pathogens.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter